These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 16514461)
1. Unusual entry to the novel 8-halo-N1-ribosyl hypoxanthine system by degradation of a cyclic adenosine-5'-diphosphate ribose analogue. Moreau C; Woodman TJ; Potter BV Chem Commun (Camb); 2006 Mar; (10):1127-9. PubMed ID: 16514461 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of 5''-branched derivatives of cyclic ADP-carbocyclic-ribose, a potent Ca2+-mobilizing agent: The first antagonists modified at the N1-ribose moiety. Sakaguchi N; Kudoh T; Tsuzuki T; Murayama T; Sakurai T; Matsuda A; Arisawa M; Shuto S Bioorg Med Chem Lett; 2008 Jul; 18(13):3814-8. PubMed ID: 18534848 [TBL] [Abstract][Full Text] [Related]
4. First enzymatic synthesis of an N1-cyclised cADPR (cyclic-ADP ribose) analogue with a hypoxanthine partial structure: discovery of a membrane permeant cADPR agonist. Wagner GK; Black S; Guse AH; Potter BV Chem Commun (Camb); 2003 Aug; (15):1944-5. PubMed ID: 12932045 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of a new N-9 ribityl analogue of cyclic inosine diphosphate ribose (cIDPR) as a mimic of cyclic ADP ribose (cADPR). Oliviero G; Amato J; Varra M; Piccialli G; Mayol L Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):735-8. PubMed ID: 16248026 [TBL] [Abstract][Full Text] [Related]
6. Cellular effects and metabolic stability of N1-cyclic inosine diphosphoribose and its derivatives. Kirchberger T; Wagner G; Xu J; Cordiglieri C; Wang P; Gasser A; Fliegert R; Bruhn S; Flügel A; Lund FE; Zhang LH; Potter BV; Guse AH Br J Pharmacol; 2006 Oct; 149(4):337-44. PubMed ID: 16967053 [TBL] [Abstract][Full Text] [Related]
8. CD38 Structure-Based Inhibitor Design Using the N1-Cyclic Inosine 5'-Diphosphate Ribose Template. Moreau C; Liu Q; Graeff R; Wagner GK; Thomas MP; Swarbrick JM; Shuto S; Lee HC; Hao Q; Potter BV PLoS One; 2013; 8(6):e66247. PubMed ID: 23840430 [TBL] [Abstract][Full Text] [Related]
9. Synthetic cADPR analogues may form only one of two possible conformational diastereoisomers. Watt JM; Thomas MP; Potter BVL Sci Rep; 2018 Oct; 8(1):15268. PubMed ID: 30323284 [TBL] [Abstract][Full Text] [Related]
10. Cyclic adenosine 5'-diphosphate ribose analogs without a "southern" ribose inhibit ADP-ribosyl cyclase-hydrolase CD38. Swarbrick JM; Graeff R; Zhang H; Thomas MP; Hao Q; Potter BV J Med Chem; 2014 Oct; 57(20):8517-29. PubMed ID: 25226087 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of stable and cell-type selective analogues of cyclic ADP-ribose, a Ca(2+)-mobilizing second messenger. Structure--activity relationship of the N1-ribose moiety. Kudoh T; Fukuoka M; Ichikawa S; Murayama T; Ogawa Y; Hashii M; Higashida H; Kunerth S; Weber K; Guse AH; Potter BV; Matsuda A; Shuto S J Am Chem Soc; 2005 Jun; 127(24):8846-55. PubMed ID: 15954793 [TBL] [Abstract][Full Text] [Related]
12. Structural determinants for N1/N7 cyclization of nicotinamide hypoxanthine 5'-dinucleotide (NHD+) derivatives by ADP-ribosyl cyclase from aplysia californica: Ca2+-mobilizing activity of 8-substituted cyclic inosine 5'-diphosphoribose analogues in T-lymphocytes. Moreau C; Wagner GK; Weber K; Guse AH; Potter BV J Med Chem; 2006 Aug; 49(17):5162-76. PubMed ID: 16913705 [TBL] [Abstract][Full Text] [Related]
13. Analogues of cyclic adenosine 5'-diphosphate ribose and adenophostin A, nucleotides in cellular signal transduction. Wagner GK; Riley AM; Rosenberg HJ; Taylor CW; Guse AH; Potter BV Nucleic Acids Res Suppl; 2003; (3):1-2. PubMed ID: 14510350 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of 7-Deaza-cyclic Adenosine-5'-diphosphate-carbocyclic-ribose and Its 7-Bromo Derivative as Intracellular Ca(2+)-Mobilizing Agents. Takano S; Tsuzuki T; Murayama T; Sakurai T; Fukuda H; Arisawa M; Shuto S J Org Chem; 2015 Jul; 80(13):6619-27. PubMed ID: 26075947 [TBL] [Abstract][Full Text] [Related]
15. 2'-deoxy cyclic adenosine 5'-diphosphate ribose derivatives: importance of the 2'-hydroxyl motif for the antagonistic activity of 8-substituted cADPR derivatives. Zhang B; Wagner GK; Weber K; Garnham C; Morgan AJ; Galione A; Guse AH; Potter BV J Med Chem; 2008 Mar; 51(6):1623-36. PubMed ID: 18303825 [TBL] [Abstract][Full Text] [Related]
16. Total synthesis of a cyclic adenosine 5'-diphosphate ribose receptor agonist. Swarbrick JM; Potter BV J Org Chem; 2012 May; 77(9):4191-7. PubMed ID: 22283398 [TBL] [Abstract][Full Text] [Related]
17. Aberrant cyclization affords a C-6 modified cyclic adenosine 5'-diphosphoribose analogue with biological activity in Jurkat T cells. Moreau C; Kirchberger T; Zhang B; Thomas MP; Weber K; Guse AH; Potter BV J Med Chem; 2012 Feb; 55(4):1478-89. PubMed ID: 22248391 [TBL] [Abstract][Full Text] [Related]
18. Concise syntheses of trifluoromethylated cyclic and acyclic analogues of cADPR. Huang X; Dong M; Liu J; Zhang K; Yang Z; Zhang L; Zhang L Molecules; 2010 Nov; 15(12):8689-701. PubMed ID: 21119564 [TBL] [Abstract][Full Text] [Related]
19. Second messenger analogues highlight unexpected substrate sensitivity of CD38: total synthesis of the hybrid "L-cyclic inosine 5'-diphosphate ribose". Watt JM; Graeff R; Thomas MP; Potter BVL Sci Rep; 2017 Nov; 7(1):16100. PubMed ID: 29170518 [TBL] [Abstract][Full Text] [Related]
20. Cyclic ADP-ribose analogues containing the methylenebisphosphonate linkage: effect of pyrophosphate modifications on Ca2+ release activity. Xu L; Walseth TF; Slama JT J Med Chem; 2005 Jun; 48(12):4177-81. PubMed ID: 15943490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]